Products - B2C

Disclaimer: Availability of products is subject to patent restrictions in countries where applicable patents are in effect.

Download PDF
Product Name Strength and Dosage form Brand/Innovator Indication Dossier Availability
RIBOCICLIB 200mg Film-coated tablets Kisqali® (Novartis) Breast cancer Q4-2026
TAMOXIFEN 10mg, 20mg Tablets Nolvadex® (AstraZeneca) Breast cancer Q3-2025
CAPECITABINE 150mg, 500mg Film-coated tablets Xeloda® (Roche) Colon cancer, gastric cancer, breast cancer YES
SUNITINIB 12.5mg, 25mg, 37.5mg, 50mg Capsules, hard Sutent® (Pfizer) Gastric cancer, Renal cell cancer, Pancreatic cancer YES
SORAFENIB 200mg Film-coated tablets Nexavar® (Bayer) Hepatocellular carcinoma YES
DASATINIB 20mg, 50mg, 70mg, 80mg, 100mg, 140mg Film-coated tablets Sprycel® (Bristol-Myers) Leukemia YES
VENETOCLAX 10mg, 50mg, 100mg Film-coated tablets Venclyxto® (Abbvie) Leukemia Q4-2026
METHOTREXATE 2.5 mg Film-coated tablets Novatrex® (Pfizer) Leukemia, non-Hodgkin's lymphoma YES
IBRUTINIB 140mg, 280mg, 420mg & 560mg Film-coated tablets Imbruvica® (Janssen) Lymphoma, Leukemia Q2-2026
IMATINIB 100mg, 400mg Film-coated tablets Glivec® (Novartis) Lymphoma, Leukemia YES

* Available for distribution only.